RT Journal Article
SR Electronic
T1 <sup>99m</sup>Tc-Depreotide Chest SPECT Demonstrates Pulmonary Metastases from Renal Cell Carcinoma
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 19
OP 21
VO 32
IS 1
A1 Shih, Wei-Jen
A1 Romero, Ramon A.L.
A1 Timothy, Mullet
A1 Milan, Primo P.
YR 2004
UL http://tech.snmjournals.org/content/32/1/19.abstract
AB 99mTc-Depreotide has been used on single pulmonary nodules to identify somatostatin receptor-positive lung cancer. We report that pulmonary metastases of a 78-y-old man with postradical nephrectomy for renal cell carcinoma were detected by 99mTc-depreotide chest SPECT. Thus, 99mTc-depreotide chest SPECT can be used to diagnose secondary lung cancer, such as pulmonary metastases from renal cell carcinoma with somatostatin receptor-positive tumor, other than primary lung cancer. Depending on whether the 99mTc-depreotide was positive for pulmonary metastases, the patient underwent an appropriate therapy without further invasive procedures.